Related Experiment Video
Updated: Jun 12, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings
G Maura1, A Gemignani, P Versace
1Istituto di Farmacologia e Farmacognosia, Università di Genova, Via Capo S. Chiara 5, 16146 Genova Italy.
Abstract:
The release of serotonin elicited by Ca(2+)-dependent stimuli (depolarization, ionophore A23187) from rat brain synaptosomes previously labelled with the radioactive indoleamine was not affected by the presence of the serotonin carrier blocker chlorimipramine. In contrast, other releasing stimuli, such as superfusion with a Na(+)-free medium or exposure to various releasing drugs (fenfluramine, p-chloroamphetamine, tryptamine and mianserin, both in normal Krebs-Ringer medium and in low-Na(+) medium), evoked efflux of serotonin from nerve endings which was prevented by chlorimipramine. The results indicate that serotonin can be released from central nerve endings by two mechanisms, differentially affected by the blockade of the membrane carrier system: the characteristics of the Ca(2+)-dependent release are compatible with an exocytotic mechanism, whereas the release induced by lack of Na(+) or by phenylethylamines and tryptamine appears to occur by outward transport mediated by the membrane carrier.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Neurochemical Transmission: Sites of Drug Action
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Modified-Release Drug Delivery Systems: Stimuli-Activated
